Lamellar Biomedical
About:
Lamellar Biomedical develops novel healthcare products based on the mimicry or modification of the lamellar body secretory system.
Website: http://lamellar.com
Top Investors: Invesco, Pitch@Palace, TRICAPITAL, Scottish Investment Bank, Barwell Plc
Description:
Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Total Funding Amount:
11.4M GBP
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Bellshill, North Lanarkshire, United Kingdom
Founded Date:
2007-06-01
Contact Email:
info(AT)lamellar.com
Founders:
James Dobbie
Number of Employees:
11-50
Last Funding Date:
2017-05-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai